Back

The influence of perindopril on endoglin plasma levels compared with other antihypertensive drugs, in a chronic treatment

27 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Vascular function as a target of cardiovascular therapy? Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Minodora Andor

University of Medicine and Pharmacy Victor Babes, Timisoara (Romania)

4 More presentations in this session

Presentation thumbnail
Doctor O. Torbas (Kiev, UA)
Abstract Slides
Presentation thumbnail
Professor R. Bruno (Paris, FR)
Abstract
Presentation thumbnail
Doctor F. Khan (London, GB)
Abstract Slides
Presentation thumbnail
Ms V. Buda (Timisoara, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Vascular function as a target of cardiovascular therapy?

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Influence of 12-month therapy with perindopril on the endothelial function in HFpEF patients in comparison with HFmrEF patients
29 June 2021
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
1 September 2025
thumbnail
Congress Presentation
Plasma aldosterone concentration / plasma renin activity ratio in patients with essential hypertension before treatment
26 August 2023
thumbnail
Congress Presentation
Hypertension in thoracic aortic aneurysm and dissection: considerations in the choice of antihypertensive agents for the long-term management
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources